INS and metabolic dysfunction-associated steatohepatitis: Studies in patients with NASH have inferred changes in adipose tissue insulin sensitivity through systemic measures of circulating NEFA which are elevated in both the fasting state and under hyperinsulinaemic conditions 6–8,12.